COVID
Clinical trials for COVID explained in plain language.
Never miss a new study
Get alerted when new COVID trials appear
Sign up with your email to follow new studies for COVID, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
COVID-19 drug study pulled before it even started
Disease control TerminatedThis study aimed to see if the drug sarilumab could help hospitalized COVID-19 patients with severe breathing problems. It planned to compare a single or double dose of sarilumab against a placebo. However, the study was withdrawn before enrolling any participants, so no results …
Matched conditions: COVID
Phase: PHASE2 • Sponsor: BayCare Health System • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
Withdrawn plasma study sought to treat severe COVID
Disease control TerminatedThis study planned to give convalescent plasma (blood from recovered COVID-19 patients) to people in the ICU with severe COVID-19 and respiratory failure. The goal was to see if it could reduce ventilator use and deaths. However, the study was withdrawn before any participants we…
Matched conditions: COVID
Phase: PHASE1 • Sponsor: Henry Ford Health System • Aim: Disease control
Last updated May 04, 2026 16:23 UTC